Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2020

Open Access 01-12-2020 | Research

Psychological functioning in children suspected for mitochondrial disease: the need for care

Authors: Kim F. E. van de Loo, José A. E. Custers, Saskia Koene, Inge-Lot Klein, Mirian C. H. Janssen, Jan A. M. Smeitink, Christianne M. Verhaak

Published in: Orphanet Journal of Rare Diseases | Issue 1/2020

Login to get access

Abstract

Background

Mitochondrial diseases (MD) are generally serious and progressive, inherited metabolic diseases. There is a high comorbidity of anxiety and depression and limitations in daily functioning. The complexity and duration of the diagnostic process and lack of knowledge about prognosis leads to uncertainty. In this study, we investigated the psychological well-being of children who are suspected for MD and their parents.

Methods

In total 122 children suspected for MD and their parents, received questionnaires as part of standard clinical investigation.

Results

Parent proxy report revealed a lower quality of life (QoL) compared to norms and even more physical problems compared to chronically ill patients. They also reported more behavioral problems in general and more internalizing problems compared to the norms. Most frequent reported somatic complaints were tiredness and pain. Parents did not report enhanced levels of stress regarding parenting and experienced sufficient social support. At the end of the diagnostic process, 5.7% of the children received the genetically confirmed diagnosis of MD, 26% showed non-conclusive abnormalities in the muscle biopsy, 54% did not receive any diagnosis, and the remaining received other diagnoses. Strikingly, children without a diagnosis showed equally QoL and behavioral problems as children with a diagnosis, and even more internalizing problems.

Conclusions

This study highlights the psychological concerns of children with a suspicion of MD. It is important to realize that as well as children with a confirmed diagnosis, children without a diagnosis are vulnerable since explanation for their complaints is still lacking.
Literature
1.
go back to reference Koene S, Wortmann SB, de Vries MC, Jonckheere AI, Morava E, de Groot IJ, et al. Developing outcome measures for pediatric mitochondrial disorders: which complaints and limitations are most burdensome to patients and their parents? Mitochondrion. 2013;13:15–24.CrossRef Koene S, Wortmann SB, de Vries MC, Jonckheere AI, Morava E, de Groot IJ, et al. Developing outcome measures for pediatric mitochondrial disorders: which complaints and limitations are most burdensome to patients and their parents? Mitochondrion. 2013;13:15–24.CrossRef
2.
go back to reference Parikh S, Goldstein A, Karaa A, Koenig MK, Anselm I, Brunel-Guitton C, et al. Patient care standards for primary mitochondrial disease: a consensus statement from the mitochondrial medicine society. Genet Med. 2017;19:1–18. Parikh S, Goldstein A, Karaa A, Koenig MK, Anselm I, Brunel-Guitton C, et al. Patient care standards for primary mitochondrial disease: a consensus statement from the mitochondrial medicine society. Genet Med. 2017;19:1–18.
3.
go back to reference Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF. The epidemiology of mitochondrial disorders--past, present and future. Biochim Biophys Acta. 1659;2004:115–20. Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF. The epidemiology of mitochondrial disorders--past, present and future. Biochim Biophys Acta. 1659;2004:115–20.
4.
go back to reference Koopman WJ, Willems PH, Smeitink JA. Monogenic mitochondrial disorders. N Engl J Med. 2012;366:1132–41.CrossRef Koopman WJ, Willems PH, Smeitink JA. Monogenic mitochondrial disorders. N Engl J Med. 2012;366:1132–41.CrossRef
5.
go back to reference Smeitink JA, Zeviani M, Turnbull DM, Jacobs HT. Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab. 2006;3:9–13.CrossRef Smeitink JA, Zeviani M, Turnbull DM, Jacobs HT. Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab. 2006;3:9–13.CrossRef
6.
go back to reference Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial medicine society. Genet Med. 2015;17:689–701.CrossRef Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial medicine society. Genet Med. 2015;17:689–701.CrossRef
7.
go back to reference Koene S, Kozicz TL, Rodenburg RJ, Verhaak CM, de Vries MC, Wortmann S, et al. Major depression in adolescent children consecutively diagnosed with mitochondrial disorder. J Affect Disord. 2009;114:327–32.CrossRef Koene S, Kozicz TL, Rodenburg RJ, Verhaak CM, de Vries MC, Wortmann S, et al. Major depression in adolescent children consecutively diagnosed with mitochondrial disorder. J Affect Disord. 2009;114:327–32.CrossRef
8.
go back to reference Morava E, Gardeitchik T, Kozicz T, de Boer L, Koene S, de Vries MC, et al. Depressive behaviour in children diagnosed with a mitochondrial disorder. Mitochondrion. 2010;10:528–33.CrossRef Morava E, Gardeitchik T, Kozicz T, de Boer L, Koene S, de Vries MC, et al. Depressive behaviour in children diagnosed with a mitochondrial disorder. Mitochondrion. 2010;10:528–33.CrossRef
9.
go back to reference Sofou K. Mitochondrial disease: a challenge for the caregiver, the family, and society. J Child Neurol. 2013;28:663–7.CrossRef Sofou K. Mitochondrial disease: a challenge for the caregiver, the family, and society. J Child Neurol. 2013;28:663–7.CrossRef
10.
go back to reference Read CY. The demands of biochemical genetic disorders: a survey of mothers of children with mitochondrial disease or phenylketonuria. J Pediatr Nurs. 2003;18:181–6.CrossRef Read CY. The demands of biochemical genetic disorders: a survey of mothers of children with mitochondrial disease or phenylketonuria. J Pediatr Nurs. 2003;18:181–6.CrossRef
11.
go back to reference Senger BA, Ward LD, Barbosa-Leiker C, Bindler RC. Stress and coping of parents caring for a child with mitochondrial disease. Appl Nurs Res. 2016;29:195–201.CrossRef Senger BA, Ward LD, Barbosa-Leiker C, Bindler RC. Stress and coping of parents caring for a child with mitochondrial disease. Appl Nurs Res. 2016;29:195–201.CrossRef
12.
go back to reference Senger BA, Ward LD, Barbosa-Leiker C, Bindler RC. The parent experience of caring for a child with mitochondrial disease. J Pediatr Nurs. 2016;31:32–41.CrossRef Senger BA, Ward LD, Barbosa-Leiker C, Bindler RC. The parent experience of caring for a child with mitochondrial disease. J Pediatr Nurs. 2016;31:32–41.CrossRef
13.
go back to reference Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800–12.CrossRef Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800–12.CrossRef
14.
go back to reference Achenbach TM, Rescorla LA. Manual for the ASEBA Preschool Forms & Profiles. Burlington: University of Vermont Research Center for Children, Youth, & Families; 2000. Achenbach TM, Rescorla LA. Manual for the ASEBA Preschool Forms & Profiles. Burlington: University of Vermont Research Center for Children, Youth, & Families; 2000.
15.
go back to reference Achenbach TM, Rescorla LA. Manual for the ASEBA school-age forms and profiles. Burlington: University of Vermont Research Center for Children, Youth, & Families; 2001. Achenbach TM, Rescorla LA. Manual for the ASEBA school-age forms and profiles. Burlington: University of Vermont Research Center for Children, Youth, & Families; 2001.
16.
go back to reference De Brock AJLL, Vermulst AA, Gerris JRM, Abidin RR. NOSI, Nijmeegse ouderlijke stress index. Lisse: Swets & Zeitlinger; 1992. De Brock AJLL, Vermulst AA, Gerris JRM, Abidin RR. NOSI, Nijmeegse ouderlijke stress index. Lisse: Swets & Zeitlinger; 1992.
17.
go back to reference Van Dam-Baggen R, Kraaimaat F. De inventarisatielijst sociale betrokkenheid (ISB): Een zelfbeoordelingslijst om sociale steun te meten. Gedragstherapie. 1992;25:27–46. Van Dam-Baggen R, Kraaimaat F. De inventarisatielijst sociale betrokkenheid (ISB): Een zelfbeoordelingslijst om sociale steun te meten. Gedragstherapie. 1992;25:27–46.
18.
go back to reference Huiskes CJAE, Kraaimaat FW, Bijlsma JWJ. IRGL, invloed van reuma op gezondheid en leefwijze. Zelfbeoordelingslijst. St Radboud, Nijmegen: Afdeling Medische Psychologie, Universitair Medisch Centrum; 2004. Huiskes CJAE, Kraaimaat FW, Bijlsma JWJ. IRGL, invloed van reuma op gezondheid en leefwijze. Zelfbeoordelingslijst. St Radboud, Nijmegen: Afdeling Medische Psychologie, Universitair Medisch Centrum; 2004.
19.
go back to reference Varni JW, Burwinkle TM, Seid M. The PedsQL 4.0 as a school population health measure: feasibility, reliability, and validity. Qual Life Res. 2006;15:203–15.CrossRef Varni JW, Burwinkle TM, Seid M. The PedsQL 4.0 as a school population health measure: feasibility, reliability, and validity. Qual Life Res. 2006;15:203–15.CrossRef
20.
go back to reference Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck depression inventory for primary care. Behav Res Ther. 1997;35:785–91.CrossRef Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck depression inventory for primary care. Behav Res Ther. 1997;35:785–91.CrossRef
21.
go back to reference Custers JAE, de Laat P, Koene S, Smeitink J, Janssen MCH, Verhaak C. Fear of disease progression in carriers of the m.3243A > G mutation. Orphanet J Rare Dis. 2018;13:203.CrossRef Custers JAE, de Laat P, Koene S, Smeitink J, Janssen MCH, Verhaak C. Fear of disease progression in carriers of the m.3243A > G mutation. Orphanet J Rare Dis. 2018;13:203.CrossRef
22.
go back to reference Verhaak C, de Laat P, Koene S, Tibosch M, Rodenburg R, de Groot I, et al. Quality of life, fatigue and mental health in patients with the m.3243A > G mutation and its correlates with genetic characteristics and disease manifestation. Orphanet J Rare Dis. 2016;11:25.CrossRef Verhaak C, de Laat P, Koene S, Tibosch M, Rodenburg R, de Groot I, et al. Quality of life, fatigue and mental health in patients with the m.3243A > G mutation and its correlates with genetic characteristics and disease manifestation. Orphanet J Rare Dis. 2016;11:25.CrossRef
23.
go back to reference Pinquart M, Shen Y. Behavior problems in children and adolescents with chronic physical illness: a meta-analysis. J Pediatr Psychol. 2011;36:1003–16.CrossRef Pinquart M, Shen Y. Behavior problems in children and adolescents with chronic physical illness: a meta-analysis. J Pediatr Psychol. 2011;36:1003–16.CrossRef
24.
go back to reference Perrin EC, Stein RE, Drotar D. Cautions in using the child behavior checklist: observations based on research about children with a chronic illness. J Pediatr Psychol. 1991;16:411–21.CrossRef Perrin EC, Stein RE, Drotar D. Cautions in using the child behavior checklist: observations based on research about children with a chronic illness. J Pediatr Psychol. 1991;16:411–21.CrossRef
25.
go back to reference Parikh S, Karaa A, Goldstein A, Bertini ES, Chinnery PF, Christodoulou J, et al. Diagnosis of 'possible' mitochondrial disease: an existential crisis. J Med Genet. 2019;56:123–30.CrossRef Parikh S, Karaa A, Goldstein A, Bertini ES, Chinnery PF, Christodoulou J, et al. Diagnosis of 'possible' mitochondrial disease: an existential crisis. J Med Genet. 2019;56:123–30.CrossRef
26.
go back to reference Mishel MH. Theories of uncertainty in illness. In: Smith MJ, Liehr PR, editors. Middle range theory for nursing. 3rd ed. New York: Springer Publishing Company, LLC; 2014. p. 53–86. Mishel MH. Theories of uncertainty in illness. In: Smith MJ, Liehr PR, editors. Middle range theory for nursing. 3rd ed. New York: Springer Publishing Company, LLC; 2014. p. 53–86.
27.
go back to reference Anderson M, Elliott EJ, Zurynski YA. Australian fmailies living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J rare dis. 2013;8:22.CrossRef Anderson M, Elliott EJ, Zurynski YA. Australian fmailies living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J rare dis. 2013;8:22.CrossRef
28.
go back to reference Zurynski Y, Deverell M, Dalkeuth T, Johnson S, Christodoulou J, Leonard H. Autstralian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays. Orphanet J rare dis. 2017;12:86.CrossRef Zurynski Y, Deverell M, Dalkeuth T, Johnson S, Christodoulou J, Leonard H. Autstralian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays. Orphanet J rare dis. 2017;12:86.CrossRef
Metadata
Title
Psychological functioning in children suspected for mitochondrial disease: the need for care
Authors
Kim F. E. van de Loo
José A. E. Custers
Saskia Koene
Inge-Lot Klein
Mirian C. H. Janssen
Jan A. M. Smeitink
Christianne M. Verhaak
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2020
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-020-1342-8

Other articles of this Issue 1/2020

Orphanet Journal of Rare Diseases 1/2020 Go to the issue